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Abstract.  Meta-vinculin, a  vinculin-related protein, 
has been isolated from human uterus smooth muscle. 
Specific antibodies to meta-vinculin, which distinguish 
between meta-vinculin and vinculin, were prepared by 
absorption of anti-meta-vinculin serum on vinculin 
coupled to nitrocellulose. Meta-vinculin specific anti- 
body demonstrates only smooth and cardiac muscle 
specificity and is able to cross-react with a  small 
21-kD  fragment of the meta-vinculin polypeptide chain. 
This antibody does not interact with protease resistant 
95-kD core shared by vinculin and meta-vinculin. 
Meta-vinculin specific antibody was used for the local- 
ization of meta-vinculin in smooth and cardiac muscles 
by the indirect immunofluorescence method. At the 
light microscopy resolution level it was found that 
meta-vinculin and vinculin are localized in the same 
cellular adhesive structures.  Meta-vinculin is present 
in membrane-associated microfilament-bound plaques 
of smooth muscle, in intercalated discs and costameres 
of cardiac muscle. In primary culture of smooth mus- 
cle cells from human aorta, meta-vinculin and vinculin 
were found to be present in focal contacts of the cells. 
During the cultivation of smooth muscle cells, the 
quantity of meta-vinculin decreased progressively and 
finally meta-vinculin completely disappeared from the 
focal contacts. The data show that in smooth and 
cardiac muscles meta-vinculin could be a  structural 
component of microfilament-membrane attachment 
sites, defined earlier by the localization of vinculin. 
I 
r  is now generally accepted that specific interactions be- 
tween microfilaments and membranes of muscle and 
nonmuscle cells play an important role in various cellu- 
lar phenomena (for review see [14, 24]).  Several proteins 
were found to be concentrated at the ends of actin filaments 
and to play an important role in the attachment of microfila- 
ments to the plasma membrane (14, 24). One of these pro- 
teins, vinculin, has a molecular mass of 130,000 D and was 
shown to be localized in the junctional plaques of all adhe- 
rens junctions, including cell-ceU contacts and cell-matrix 
adhesions (5, 12, 15, 16, 19, 29, 30, 36). Vinculin was found 
in focal contacts of cultured cells, zonula adherens of intesti- 
nal epithelial cells, intercalated discs of cardiac muscle and 
myofibril-sarcolemma attachment regions ("costameres') in 
striated muscles (5, 12, 15, 16, 19, 29, 30, 36). Vinculin was 
shown to be expressed in many cell types, notably in blood 
platelets (21, 32). 
Recently, a vinculin-related protein with a molecular mass 
of ,,o150,000 D has been isolated from chicken gizzard and 
porcine stomach smooth muscle (11, 17, 35).  This protein 
was termed as meta-vinculin (34).  Unlike vinculin, the ex- 
pression ofmeta-vinculin is restricted to muscle cells (11, 17, 
18,  33).  Amino acid analysis, peptide mapping, and two- 
dimensional gel electrophoretic analysis demonstrated a high 
degree of structural relatedness between meta-vinculin and 
vinculin 01,  17, 35).  The difference between the molecular 
masses of vinculin and meta-vinculin, which is •20,000  D, 
enables us to distinguish these proteins by immunoblotting 
(11, 34). An antibody generated to meta-vinculin completely 
cross-reacted with vinculin, making the immunolocalization 
of meta-vinculin in different tissues impossible. The results 
of in vivo and in vitro experiments led us to suggest that vin- 
culin and meta-vinculin do not have a precursor-product re- 
lationship and are distinct proteins,  arising from separate 
mRNAs (11, 35). Both meta-vinculin and vinculin have the 
ability to  interact specifically with talin,  a-actinin and a 
175-kD membrane protein (1, 6, 7, 20, 27, 40, 41). 
In this paper we present immunofluorescent  localization of 
meta-vinculin in human smooth and cardiac muscles.  We 
report that at the light microscopy resolution level meta-vin- 
culin has the same location in smooth and cardiac muscles 
as had been previously demonstrated for vinculin.  Meta- 
vinculin was found in membrane-associated  plaques of smooth 
muscle, in focal contacts of cultured smooth muscle cells, in 
intercalated discs and costarneres of cardiac muscle. 
Materials and Methods 
Purification of  Meta-vinculin and Vinculin from 
Human Uterus Smooth Muscle 
Human  uterus smooth  muscle  vinculin  and meta-vinculin  were isolated  ac- 
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muscle from human uterus were homogenized in a Waring Blendor with 2 1 
of deionized  water  containig  0.5  mM  phenylmethyl  sulfonyl  fluoride 
(PMSF). The supernatant was discarded and the pellet was resuspended in 
2 1 of buffer containing 20 mM Tris, 1 mM EGTA, 0.5 mM PMSF, pH 9.0. 
The suspension was stirred  for 60 min at 37"C. The centrifugation was 
repeated and the pellet discarded.  The supernatant was saved and the pH 
was adjusted to 7.2 with acetic acid, after that  1 M MgCI2 was added to 
make 10 raM, which stimulated F-actin precipitation. After centrifugation 
(10 min at 12,000 rpm in JA-14 rotor, Beckman Instruments, Inc. Berkeley, 
CA) the supernatant was ammonium sulfate fractionated by the addition 
of, firstly, 14.9 g (NI-hhSOdl00  ml and then after centrifugation  6.8 g 
(Nl-h)2SOdl00 ml more  were added to the supernatant.  The precipitate 
was collected, dissolved and dialyzed against a buffer containing 20 mM 
NaCI, 0.1 mM EDTA, 0.5 mM DTT, 5 mM Tris-HCI, pH 7.6 (Buffer A). 
After dialysis the proteins were fractionated on a column of  DE-52 cellulose 
(2.6 × 22 cm) equilibrated in Buffer A. Five major peaks of optical density 
were  eluted  from the  column.  The  first one corresponded  to  vinculin 
(,'~70% pure).  The second peak was enriched in meta-vinculin (50-60% 
pure) as established by SDS-gel electrophoresis. The pooled vinculin and 
meta-vinculin fractions were dialyzed aganst Buffer A and then were applied 
to 0.9  x  10 cm columns with hydroxyapatite resin (Bio-Rad Laboratories, 
Cambridge, MA). Bound proteins were eluted from column with a linear 
gradient from 0 to 0.2 M K-phosphate, in Buffer A, pH 7.6. Fractions con- 
tainiag meta-vinculin and vinculin were pooled, concentrated and stored at 
-70°C. 
Production and Characterization of  Antibody 
Antibody to human uterus smooth muscle vinculin was purified from rabbit 
anti-vinculin  serum by affinity chromatography and characterized  as de- 
scribed previously (18). 
Antibody to human uterus meta-vinculin was obtained by immunization 
of BALB/c mice with 0.1 mg of highly purified meta-vinculin (more than 
99 % pure) in complete Freund's adjuvant intraperitoneaUy. 4 w later, the 
mice were boosted with 0.05 mg of meta-vinculin, and then after another 
2 w the mice were boosted again with 0.05 nag of the antigen (two times). 
The mouse serum was collected and stored in aliquots at -20"C. The ab- 
sorption of anti-meta-vinculin antiserum on nitrocellulose strips coupled to 
electrophoretically  transferred  ho:nogenous  human  uterus  vinculin  was 
done according to (37). The nitrocellulose strip (14  x  1.5 cm) containing 
"ol  nag of vinculin was incubated during 2 h with  1.5  ml of anti-meta- 
vinculin antiserum and this procedure was repeated until the antiserum was 
unable to interact with vinculin.  The last step was to purify antibody to 
meta-vinculin from mouse serum by affinity chromatography. 
In Western blots of proteins from human uterus smooth muscle, the affin- 
ity-purified anti-meta-vinculin antibody reacted only with meta-vinculin. 
lmmunofluorescence Labeling 
Freshly isolated human uterus myometrium  and cardiac muscle were dropped 
into freezing isopentane. 3-4 I~m longitudinal and transverse cryostat sec- 
tions were cut at ,,o-15oc. Sections were mounted onto glass slides. All sec- 
tions were incubated in PBS for 5 min before staining at room temperature. 
For indirect immunofluorescence labeling the sections were incubated with 
primary affinity-purified anti-meta-vinculin  and anti-vinculin  IgG's (0.02 
mg/ral) for 60 min at 37°C. Sections were washed in PBS over 30 min and 
then fluorescein-conjugated goat anti-rabbit  IgG (diluted 1:40) and rhoda- 
mine-conjugated goat anti-mouse IgG (diluted 1:40) were added.  After a 
further incubation for 45 rain with secondary antibodies the sections were 
washed and mounted in PBS with 50 % (wt/vol) glycerol. The stained tissues 
were examined on a Zeiss epifluorescent photomicroscope IlI with 40x and 
100x  objectives. Photographs were taken with Kodak Tri-X film. Controls 
were performed  in which the primary  antibodies  were replaced by: (a) 
preimmune serum (dilution 1:10); (b) antibodies to meta-vinculin and vincu- 
lin that had been absorbed in advance by an excess of their respective anti- 
gens coupled to nitrocellulose. 
Cell Culture 
Smooth muscle cells from tunica media of human aorta were isolated by 
collagenase-clastase digestion (8), and cultured in Dulbecco's modified Ea- 
gle's medium (DME) (Flow) supplemented with 10 mM Hepes, 6.6 mg/ml 
sodium pyruvate, 50 I~g/ml ascorbic acid, 0.6 mg/ml L-glutamine, 50 gg/ml 
gentamicin sulfate and  10% heat-inactivated human serum. 
Other Methods 
To perform SDS-PAGE, the buffer of  Laemmli (22) was used. Immunobiot- 
ring analysis was done according to the procedure of Towbin et al.  (39). 
Eiectrotransfer was carried out for 3 h at 400 mA current. The blots were 
stained by indirect immunoperoxidase technique.  The first antibody was 
mouse anti-meta-vinculin  IgG. The secondary antibody was horseradish 
peroxidase-conjugated rabbit (anti-mouse  IgG) IgG. 4-Chloro-l-naphthol 
(Sigma Chemical Co., St. Louis, MO) was used as a substrate for peroxi- 
dase.  The blue colour developed after 2 min of substrate addition.  Two- 
dimensional electrophoresis was done as described by O'Farrell (28) with 
slight modifications~  Ampholytes used in the lysis buffer and IEF gels were 
composed of 0.27% Ampholine pH range 3.5-10 (LKB Instruments, Inc.), 
1.6% Ampholine pH range 5-7 and 0.8% Ampholine pH range 5-8. 
Results 
Purification and Properties of  Meta-Vinculin  from 
Human Uterus Smooth Muscle 
Purification of human uterus  smooth muscle meta-vinculin 
was done according to the modified protocols developed for 
meta-vinculin isolation from chicken gizzard smooth muscle 
(10, 11,  35).  After selective extraction from human uterus 
smooth muscle,  meta-vinculin was purified by two steps of 
chromatography on DE-52 and hydroxyapatite columns, while 
other methods  used  for meta-vinculin  preparation  include 
three chromatographic steps. Meta-vinculin eluted from hy- 
droxyapatite  column was at least 99 % pure (Fig.  1 b), and 
was able to cross-react with affinity purified anti-vinculin an- 
tibody  in  a  Western  blot  (Fig.  1  c).  The  final  yield  was 
,,o4 mg of meta-vinculin from 300 g wet weight of human 
uterus. 
The analytical sedimentation analysis also demonstrated 
the high degree of  homogeneity  of  the meta-vinculin prepara- 
tion; the protein sedimented as one boundary and with a 
sedimentation coefficient Sw,2o  c =  6.5  ±  0.5, high molecu- 
lar weight aggregates were not revealed in the preparation 
(not shown). 
Figure 1. Homogeneity analysis of  the human uterus smooth muscle 
meta-vinculin:  (a)  two-dimensional electrophoresis of  purified 
meta-vinculin;  (b)  SDS-polyacrylamide gel  analysis of purified 
meta-vinculin; (c) immunoblot of the same sample as shown in (b) 
with anti-vinculin antibody. 
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I a) demonstrate that meta-vinculin has at least two isoforms. 
The isoform that accounts for 70%  of total meta-vinculin 
amount, has a pI of 5,78. The minor meta-vinculin ¢t-isoform 
has a pl of 5.70. 
Human uterus smooth muscle meta-vinculin isoforms are 
more acidic than those from chicken gizzard smooth muscle 
(the ~t-isoform has a pI of 5.88 and the I~-isoform, pI of 6.18) 
(35).  Unlike  human,  avian  smooth  muscle  meta-vinculin 
ct-isoform has been shown to predominate (35). Two-dimen- 
sional gel electrophoresis of porcine stomach meta-vinculin 
revealed several isoelectric variants which were more basic 
than  those  found in  human  uterus  smooth  muscle and  in 
chicken gizzard (17). Therefore, meta-vinculin isoform anal- 
ysis demonstrated that not only avian and mammalian meta- 
vinculin differ significantly, but also there is a certain vari- 
ability within the mammalian meta-vinculins too, 
Highly purified mammalian  meta-vinculin was  checked 
for its ability to bindTriton X-114 detergent according to (4). 
This was done to probe the presence of hydrophobic domains 
in the protein. Much like the avian meta-vinculin (35), hu- 
man uterus meta-vinculin was present in the aqueous phase 
(not shown), which means that metaovinculin has no solubil- 
ity properties typical of integral membrane proteins. 
Specificity of  Antibody to Meta-Vinculin 
For the immunocytochemical and immunoblot analyses de- 
scribed below, antibody specific to meta-vinculin was used. 
The murine antiserum to human uterus smooth muscle meta- 
vinculin recognized both meta-vinculin and vinculin (Fig. 2). 
This antiserum was absorbed six times on strips of nitrocel- 
lulose  paper  coupled to  electrophoretically homogeneous 
human uterus vinculin. The meta-vinculin specific antibody 
that did not bind to vinculin-nitrocellulose was unable to re- 
act with vinculin in immunoblots of meta-vinculin and vin- 
culin preparations (Fig. 2). This antibody was further affin- 
ity-purified on meta-vinculin-Sepharose and was used for the 
detection of meta-vinculin. Fig. 2 B demonstrates that atiin- 
ity-purified anti-meta-vinculin antibody recognized only the 
150-kD polypeptide in immunoblots of preparations of mus- 
cle proteins from human uterus, aorta, and heart, and did not 
interact with purified vinculin or any polypeptide from hu- 
man fibroblast extract; skeletal (sartorius) muscle contained 
only trace amounts of meta-vinculin (Fig. 2 C). To exclude 
the possibility that antibodies reactive with SDS-sensitive 
epitopes of vinculin were still present in our preparation of 
meta-vinculin specific antibody, we used a quantitative im- 
munoassay with anti-meta-vinculin on nondenatured vincu- 
lin.  We did not find any cross-reactivity of meta-vinculin 
specific antibody with nondenatured vinculin as well (not 
shown). Thus, we have obtained meta-vinculin specific anti- 
body suitable for the localization of meta-vinculin in differ- 
ent tissues. 
In light of the extreme similarity of vinculin and meta- 
vinculin, revealed by antibody cross-reactivity (Fig. 2  and 
reference 11), it was important to study the meta-vinculin do- 
main with which meta-vinculin specific antibody interacted. 
This was done by the following methods. Meta-vinculin was 
digested  at  37°C  by  Staphilococcus  aureus  V-8  protease 
added at 1:100 (wt/wt) to the purified protein. The peptides 
which had  undergone such a  digestion were examined by 
Figure 2. Analysis of specificity of anti-meta-vinculin antibody. (A) 
SDS-polyacrylamide gel analysis of extracts from different human 
tissues.  Proteins  were  visualized  by  Coomassie  Blue-staining. 
(Lanes a and b) Mixture of meta-vinculin (150 kD) and vinculin 
(130 kD); (lane c) uterus; (lane d) tunica mex~ia  from aorta; (lane 
e) cardiac muscle; (lane f) foreskin fibroblasts. (B) Detection of 
meta-vinculin in different tissues. Lanes a-f show the  immuno- 
blots of gels a-f from A.  In a  nonabsorbed  on vinculin-nitro- 
cellulose anti-meta-vinculin antiserum was used; in b-f six times 
absorbed  on  vinculin-nitrocellulose  anti-meta-vinculin  affinity 
purified antibody was used. (C) Detection ofmeta-vinculin and vin- 
culin in human skeletal muscle. (Lane a) Coomassie Blue-stained 
gel of extract from human skeletal muscle; (lane b) immunoblot of 
gel (a) with antibody to vinculin; (lane c) immunoblot of gel (a) 
with antibody to meta-vinculin. 
Figure 3. Interaction of meta-vinculin antibody with different meta- 
vinculin fragments. (A) SDS-polyacrylamide  gel analysis of the 
digestion products of meta-vinculin obtained by the action of S. 
aureus V-8 protease. Meta-vinculin was incubated with protease for 
0 min (gel a), 2 rain (gel b),  15 min (gel c) and 180 rain (gel d). 
The reaction was stopped by the addition of hot SDS-gel sample 
buffer. The position of molecular mass markers (from top to bot- 
tom) are indicated by the lines: phosphorilase b (94 kD), albumin 
(67 kD), ovalbumin (43 kD), carbonic anhydrase (30 kD), trypsin 
inhibitor (20 kD), u-lactalbumin (14.4 kD). (B) Immunoblots of  the 
same samples as shown in A as obtained using anti-meta-vinculin 
specific antibody. 
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Figure 4.  Model  for the  se- 
quential fragmentation of in- 
tact meta-vinculin with S. au- 
reus V-8 protease.  (I and H) 
two possible ways for 42-kD 
fragment fragmentation.  Meta- 
vinculin-specific antibody re- 
active fragments are shown as 
solid bars. 
SDS-PAGE and immunoblotting with meta-vinculin specific 
antibody. Meta-vinculin was degraded first to fragments with 
approximate sizes of 130,  115, 95, 42, 32, and 21 kD (Fig. 
3 A). In the course of digestion the 130-,  115-, and 42-kD 
fragments disappeared from the digestion mixture, as it is 
seen in 15- and 180-min digest products (Fig. 3 A) and new 
fragments with approximate sizes of 55, 28,  and 18 kD ap- 
peared. Immunoblotting analysis of the meta-vinculin frag- 
ments with the meta-vinculin specific antibody demonstrated 
that the meta-vinculin specific antibody was able to interact 
only  with  small  pieces  of meta-vinculin  with  molecular 
masses of 42, 32, and 21 kD (Fig. 3 B), and did not cross- 
react with the large 95 kD fragment, shared by vinculin and 
meta-vinculin (11, 17, 25,  35). Fig. 4  summarizes the pro- 
posed scheme of intact meta-vinculin fragmentation by S. 
aureus V-8, emphasizing the presence of definite meta-vin- 
culin epitopes on the terminus of the meta-vinculin molecule 
which are absent from the vinculin molecule. At the present 
moment it remains unclear from which terminus of the meta- 
vinculin molecule the fragment binding anti-meta-vinculin 
specific antibody originates. 
Meta-Vinculin Localization in Different 
Human Muscles 
To localize meta-vinculin in muscles, cryostat sections of hu- 
man uterus,  skeletal and cardiac muscles were studied by 
double indirect immunofluorescent labeling, using affinity- 
purified antibodies to meta-vinculin (murine IgG) and vincu- 
lin  (rabbit IgG).  In  all  experiments,  immunofluorescence 
was  specific:  no  staining  was  observed when  anti-meta- 
vinculin antibody was  preabsorbed with  meta-vinculin or 
when nonlmmune IgG was used (not shown). 
Human  Uterus 
Indirect immunofluorescence staining of sections of human 
uterus  with antibodies  against  meta-vinculin and  vinculin 
demonstrated that meta-vinculin was mainly concentrated in 
Figure 5. Immunofluorescence 
localization of meta-vinculin 
in human uterus. The sections 
were double labeled with rho- 
damine-anti-meta-vinculin (a 
and  c)  and  fluorescein-anti- 
vinculin (b and d). (c and d) 
Transverse sections of human 
uterus  smooth  muscle  cells. 
Bars: (a and b) 10 ~tm; (c and 
d) 20 I.tm. 
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d).  Antibody  to  vinculin also  cross-reacted with  smooth 
muscle cells, but additionally stained connective tissue cells. 
Thus, these results confirm the high specificity of the meta- 
vinculin antibody. In accordance with immunoblotting ex- 
periments (Fig. 2) meta-vinculin specific antibody was able 
to distinguish between smooth muscle cells and fibroblasts 
of connective tissue. The fluorescence staining of transverse 
sections of human uterus smooth muscle for meta-vinculin 
and vinculin exhibited identical dotted labeling along the cell 
periphery, which corresponds to membrane-bound micro- 
filament-associated dense plaques (Fig. 5, a and b). No stain- 
ing was detected intracellularly. 
Human Cardiac and Skeletal Muscles 
When transverse sections of human cardiac muscles were ex- 
amined (Fig. 6, a and b) we observed that fluorescence was 
confined to cell margins. In addition, there was some stain- 
ing of structures removed from cell margins,  which corre- 
sponded to membrane invaginations (30). Occasional bright 
patches of staining correspond to vessels. The localization of 
meta-vinculin is very similar to that observed earlier for vin- 
culin (19, 30).  It seems that meta-vinculin is concentrated 
very close to the sarcolemmal membrane. Immunofluores- 
cent analysis of longitudinal sections of  cardiac muscle dem- 
onstrated two main types of meta-vinculin localization (Fig. 
6 c): (a) meta-vinculin is located in cell-cell contact regions, 
intercalated discs; (b) meta-vinculin's spots are periodically 
distributed along  the  cell margins  and  correspond to the 
I-bands of sarcomeres around Z-line region. Since there was 
no difference in the distribution of meta-vinculin and vincu- 
lin in the same cardiomyocyte (Fig. 6, d and e) it is possible 
to suggest that in cardiac muscle meta-vinculin is a compo- 
nent of myofibril-to-sarcolemmal  membrane attachment sites, 
costameres. Immunofluorescence staining of human skeletal 
muscle transverse sections did not allow us to localize meta- 
vinculin in the tissue (Fig. 7). While the anti-vinculin anti- 
body interacted with cell margins (Fig. 7 b), anti-meta-vin- 
culin antibody, under conditions of the experiment, practically 
did not stain the section (Fig. 7 a). 
Figure 6. Fluorescence micrographs of meta-vinculin (a, c, and d) and vinculin (b and e) distribution in human cardiac muscle. Transverse 
section of  cardiac muscle was double labeled with rhodamine-anti-meta-vinculin (a) and fluorescein-anti-vinculin (b). Longitudinal section 
of cardiac muscle was labeled with rhodamine-anti-meta-vinculin  (c) and double labeled with rhodamine-anti-meta-vinculin  (d) and 
fluorescein-anti-vinculin (e). Meta-vinculin and vinculin are associated with intercalated discs (small arrow) and with costameres (large 
arrow).  Bars, 10 gm. 
Belkin et al. Meta-Vinculin in Smooth and Cardiac Muscles  549 Figure 7. Fluorescence mierographs of  meta-vinculin (a) and vincu- 
lin (b) distribution in transverse section of human skeletal muscle. 
Bar, 20 Ixm. 
Human Aorta Smooth Muscle Cells 
Fig. 8 demonstrates the patterns of meta-vinculin and vincu- 
lin organization in human aorta smooth muscle cells (pri- 
mary culture, sixth day). In individual adherent smooth mus- 
cle  cells  (Fig.  8,  a  and  b)  the  distribution  patterns  of 
meta-vinculin and vinculin were essentially identical. Both 
proteins were present and had patch-like distribution at sites 
along the cell periphery. These sites are known to correspond 
to cell focal contacts (5,  12), Double fluorescent labeling of 
aorta smooth muscle cell for actin and meta-vinculin indi- 
cated that meta-vinculin-rich plaques were associated with 
termini of F-actin bundles (Fig.  8, c and d).  To determine 
whether meta-viriculin distribution in smooth muscle cells 
was altered during cell cultivation, we analyzed meta-vin- 
culin and vinculin localization in primary culture of  cells iso- 
lated from tunica media of human aorta. These cells did not 
proliferate up to 10-12 d of cultivation. On the third day of 
cultivation both meta-vinculin and vinculin were revealed in 
focal contacts (Fig. 9, a and b), while by the seventh day in 
culture meta-vinculin was reduced significantly (Fig. 9, c and 
d), and on the fourteenth day, only vinculin could be detected 
in the focal contacts formed by cultivated smooth muscle 
cells (Fig.  9,  e  and f). It should be mentioned that meta- 
vinculin was reduced progressively and simultaneously in all 
the focal contacts. 
Discussion 
Vinculin is  now considered to be a  ubiquitous  marker of 
microfilament-membrane association sites (15, 24).  Several 
groups of investigators have demonstrated the existence of 
vinculin variants (closely related immunologically), but dif- 
fering in isoelectric point, and in molecular mass (130 kD, 
vinculin;  150  kD,  meta-vinculin).  Some  of the  variants, 
namely y-vinculin and  meta-vinculin,  were found only in 
muscles (12,  14).  The abundance of meta-vinculin relative 
to vinculin varies depending on the muscle type (2,  11,  17, 
33). In vascular smooth muscle, and myometrium the share 
of meta-vinculin is 40-50%, while in stomach, bladder, and 
esophagus smooth muscle there is a predominance of meta- 
vinculin over vinculin (2, 17). In heart muscle meta-vinculin 
accounts for ,o20% of total vinculin (meta-vinculin +  vincu- 
lin), and only trace amounts of meta-vinculin if any were re- 
vealed in human adult skeletal muscle (2, 18). The purpose 
of this study was to localize meta-vinculin in different mus- 
cles using meta-vinculin specific antibody in the indirect im- 
munofluorescence procedure. 
Localization of  Meta-Vinculin in Cardiac and 
Smooth Muscles 
At the light microscopy resolution level, we have detected 
meta-vinculin in memrane associated dense plaques of hu- 
man uterus smooth muscle, in intercalated discs and costa- 
meres of  cardiac muscle. Under conditions of  the experiment 
we were unable to localize meta-vinculin in human adult 
skeletal muscle with the immunofluorescence method. Ac- 
cording  to  immunoblotting  data  the  proportion  of meta- 
vinculin in skeletal muscle is rather low, the protein accounts 
for only 6-8% of vinculin/meta-vinculin total amount (data 
not shown).  The possibility that meta-vinculin detected in 
skeletal muscle by immunoblotting originates from blood 
vessels which might be present in the tissue sample cannot 
be disregarded completely. Therefore, it is  still  not clear 
whether adult  human  skeletal muscles  contain any  meta- 
vinculin, or the immunofluorescence method is not sensitive 
enough to reveal this low abundant protein. 
Since  smooth  and  cardiac  muscles  contain  significant 
amounts of both vinculin and meta-vinculin, the data on vin- 
culin localization in these tissues  have to be reevaluated. 
Meta-vinculin specific antibody enabled us to localize meta- 
vinculin, while the reaction with an antibody recognizing 
both  vinculin and  meta-vinculin can  reflect a  disposition 
of either both vinculin and meta-vinculin or meta-vinculin 
alone.  Therefore,  since  vinculin-specific  antibody  is  not 
available, vinculin cannot be localized directly in the tissues 
containing both proteins. However, the direct localization of 
at least one of the proteins (meta-vinculin) combined with 
biochemical and immunochemical data led us to propose that 
vinculin and meta-vinculin colocalize in cardiac and smooth 
muscles. It should be noted that according to immunofluores- 
cence, immunoelectron microscopy and selective extraction 
data in muscles, vinculin and meta-vinculin are concentrated 
in structural elements of the cell (5,  10,  15,  16,  17,  19, 23, 
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Cells were double labeled with rhodamine-anti-meta-vinculin (a) and with fluorescein-anti-vinculin (b); with fluorescein-anti-meta- 
vinculin (c) and rhodamine-phalloidin (d).  Bars, 10 gm. 
29, 30, 33, 34, 36, 38). Also, in smooth muscle, antibody to 
vinculin/meta-vinculin  similar to meta-vinculin specific anti- 
body interacts exclusively with the antigen localized in mem- 
brane-associated dense plaques (15, 34, 36), in cardiac mus- 
cle,  in intercalated discs and costameres (16, 19,  30,  38). 
Immunoblotting analysis has revealed vinculin in isolated 
fascia adherens of  intercalated disc membrane (23). In skele- 
tal human adult muscle, which contains a very low propor- 
tion of meta-vinculin if any,  vinculin was found in costa- 
meres. Furthermore, microinjection of fluorescently labeled 
meta-vinculin and vinculin into cultured myocytes suggests 
that vinculin and meta-vinculin have the same location in the 
costameres of developing skeletal muscle cells (33).  Thus, 
it seems unlikely that costameres in the cardiac muscle are 
devoid of vinculin. 
Localization of  Meta-VincuUn in Cultured Smooth 
Muscle Cells 
Since meta-vinculin is restricted to muscles, among highly 
differentiated cells  containing the protein  smooth muscle 
cells are the only type that can be easily cultivated for a 
prolonged period of time. In the smooth muscle, vinculin is 
located in membrane-associated dense plaques (15, 16, 36), 
while in cultivated cells it appears to be involved in cell- 
substrate focal contact formation (12,  24).  Double immu- 
nofluorescence staining of human aorta smooth muscle cells 
(primary  culture)  with:  (a)  anti-meta-vinculin and  anti- 
vinculin antibodies, and (b) anti-meta-vinculin antibody and 
rhodarnine-phalloidin demonstrated that meta-vinculin and 
vinculin were both present in focal contacts. Microinjection 
of fluorescently labeled meta-vinculin into fibroblasts done 
by another group also showed codistribution of vinculin and 
meta-vinculin in focal contacts (33). 
Immunochemical studies have shown that meta-vinculin is 
progressively reduced  in human vascular  smooth muscle 
cells in the course of primary culture and can hardly be de- 
tected by the onset of intensive cell division (18). In subcul- 
tured smooth muscle cells very little meta-vinculin, if any, 
Belkin et al. Meta-Vinculin  in Smooth and Cardiac Muscles  551 Figure 9. Disappearance of meta-vinculin  from focal contacts of primary huan aorta smooth muscle cells.  Cells were double labeled with 
fluorescein-anti-vinculin (b, d, and f) and rhodamine-anti-meta-vinculin (a, c, and e). The cells were cultured  during 3 d (a and b), 7 d 
(c and d) and  14 d (e and f).  Bar,  10 I.tm. 
was revealed (18).  Meta-vinculin specific antibody enabled 
us to follow this process in an immunomorphological study: 
when  the  cells just  finished  spreading,  meta-vinculin  was 
present in all the focal contacts revealed by anti-vinculin an- 
tibodies,  whilst  in the  course  of primary culture  it disap- 
peared  from all the focal contacts simultaneously.  Smooth 
The Journal of Cell Biology. Volume 107, 1988  552 muscle cells are known to undergo phenotype modulation (8) 
when grown in culture, and meta-vinculin, like ?-isoform of 
vinculin  (2),  can  serve  as  a  marker  of the  "contractile" 
smooth muscle cell.  Therefore, the mechanisms  regulating 
molecular diversity of vinculin in development, in pathologi- 
cal state,  as well as during adaptation to culture conditions 
have to be studied.  Now,  since vinculin c-DNA  from non- 
muscle source has been cloned and several vinculin c-DNA 
clones are available (3, 9, 30), they can be applied to inves- 
tigate  the  expression  of vinculin/meta-vinculin gene(s)  in 
muscle cells. 
Taken together, our observations suggest that at the light 
microscopy resolution level meta-vinculin and vinculin co- 
localize  in smooth and cardiac  muscles,  and in cultivated 
smooth muscle cells.  It seems  that there is no subcellular 
sorting of vinculin and meta-vinculin in different muscles. 
The reason for the presence of two very similar proteins 
in the junctional structures of smooth and cardiac muscles 
remains obscure. Vinculin and meta-vinculin have the same 
solubility, characteristic tail and head structures revealed by 
electron microscopy, and the same ability to interact with ta- 
lin and ~t-actinin (1,  10, 25, 26,  35).  However, it should be 
mentioned that in vivo avian smooth muscle meta-vinculin 
is  more phosphorylated than vinculin (35) but the signifi- 
cance of this fact is poorly understood. Immunofluorescence 
investigation did not allow us to determine the relative spatial 
arrangements of vinculin and meta-vinculin in vivo. The pos- 
sibility should be taken into account that one of the proteins 
might be concentrated at a closer proximity to the plasma 
membrane and be directly involved in the linkage of actin 
filaments to the cell membrane. Irnmunoelectron microscopy 
studies could help to clarify this question. 
Received for publication  18 February  1988,  and in revised form 26 April 
1988. 
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